On the other hand, hypoxia renders EGFRM+ NSCLC cell lines TKI-resistant through activation of insulin-like growth factor 1 receptor (IGF1R), a known negative prognostic marker in advanced NSCLC [233,234]. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.